In patients with neurological disease, such as ischemic stroke [10,14,15], intracereberal hemorrhage [18,20] and traumatic head injury [19], copeptin seems to be an excellent marker for both neurological outcome and short- and mid-term mortality. Here, AVP is linked to nervous system disorder.